Optimism sweeps Latin America boosting the implementation of healthcare reform and opportunities for investment
This article was originally published in Clinica
The Latin American healthcare market is set to maintain high levels of growth and improvement in standards, heralded by the region's relative political stability, ongoing reforms, increased levels of domestic and foreign investment and positive economic indicators. This was the conclusion of speakers at the seminar of the Latin American Trade Advisory Group (LATAG), held earlier this month in Leeds, UK.
You may also be interested in...
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.
The French major and Regeneron have racked up another indication for Dupixent with the blockbuster getting approval in Europe to treat children with severe eczema.
Russia says it will make the first deliveries of its $10-per-dose Sputnik V vaccine in January, while international regulators say vaccine trials should continue for as long as possible to generate longer-term evidence on their benefits and risks. A UK research body has stressed that drugs repurposed for COVID-19 also need to undergo thorough safety and efficacy testing as reports suggest the UK regulator could approve a vaccine within days.